Company / Shares Outstanding
Haemonetics Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
50.8M
FY2025
5-year range
50.4M / 51.4M
FY2021-FY2025
Trend
+0.7%
vs FY2024
Sector context
#118 of 165
Health Care
What the data says
At 50787859.00, Haemonetics's shares outstanding ranks #48 of 165 in the Health Care sector. Shares Outstanding returned to growth in FY2025 after 2 years of decline, reaching 50787859.00.
Based on SEC 10-K filings.
50787859.00 in FY2025 with a 5-year CAGR of -0.2%.
Remained stable around 50787859.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -0.4%
- 5-Year CAGR
- -0.2%
- 10-Year CAGR
- -
Sector benchmark
#48 of 165 in Health CareTop 28% of 165This company 50.8M Sector average 170.3M
▼
-70.2% below sector average
Key checks
Key Insights
- In FY2025, shares outstanding increased 0.7% year-over-year.
- Ranks #118 out of 165 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2018.
- Lowest shares outstanding in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 50.8M | +0.7% |
| FY2024 | 50.4M | -1.8% |
| FY2023 | 51.4M | -0.0% |
| FY2022 | 51.4M | +0.1% |
| FY2021 | 51.4M | +0.1% |
| FY2020 | 51.3M | -1.0% |
| FY2019 | 51.8M | -0.8% |
| FY2018 | 52.3M | +2.6% |
| FY2017 | 50.9M | -1.4% |
| FY2016 | 51.7M | -0.7% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026